Status:
COMPLETED
Exploration of the Synovial Fluid Inflammation Mediators Under Diacerhein in Knee Osteoarthritis
Lead Sponsor:
Laboratoires NEGMA
Conditions:
Osteoarthritis
Eligibility:
All Genders
45-80 years
Phase:
PHASE4
Brief Summary
Some inflammation mediators, notably IL-1, are implied in the joint degeneration phenomena of osteoarthritis. The aim of this study is to confirm in vivo the favourable effect of diacerhein on IL-1 an...
Eligibility Criteria
Inclusion
- Painful osteoarthritis
- Hydarthrosis (synovial effusion)
Exclusion
- large effusion
- severe pathologies
- anti-osteoarthritic treatments
Key Trial Info
Start Date :
March 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2008
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT00440661
Start Date
March 1 2007
End Date
October 1 2008
Last Update
March 4 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rheumatologic Institut of Montreal
Montreal, Quebec, Canada, H2L1S6